{
     "PMID": "1330064",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19921209",
     "LR": "20141120",
     "IS": "0959-4965 (Print) 0959-4965 (Linking)",
     "VI": "3",
     "IP": "9",
     "DP": "1992 Sep",
     "TI": "Redox modulation of NMDA receptor-mediated synaptic activity in the hippocampus.",
     "PG": "781-4",
     "AB": "The sulfhydryl reducing agent dithiothreitol (DTT) and the oxidizing agent 5,5-dithio-bis-2-nitrobenzoic acid (DTNB) reversibly modulate the component of synaptic potentials mediated by N-methyl-D-aspartate (NMDA) receptors in slices of hippocampal area CA1. DTT (1 mM) reversibly potentiates NMDA receptor-mediated synaptic potentials while DTNB (1 mM) has the opposite effect. However, treatment of the slices with the irreversible sulfhydryl alkylating agent N-ethylmaleimide (300 microM) prevents DTNB from reversing the potentiation induced by DTT. These results further implicate the redox modulatory site as a regulator of the NMDA receptor-channel complex in vivo.",
     "FAU": [
          "Tauck, D L"
     ],
     "AU": [
          "Tauck DL"
     ],
     "AD": "Department of Biology, Santa Clara University, California 95053.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "Neuroreport",
     "JT": "Neuroreport",
     "JID": "9100935",
     "RN": [
          "0 (Receptors, N-Methyl-D-Aspartate)",
          "9BZQ3U62JX (Dithionitrobenzoic Acid)",
          "T8ID5YZU6Y (Dithiothreitol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Dithionitrobenzoic Acid/pharmacology",
          "Dithiothreitol/pharmacology",
          "Hippocampus/drug effects/*metabolism",
          "In Vitro Techniques",
          "Male",
          "Oxidation-Reduction",
          "Rats",
          "Rats, Sprague-Dawley",
          "Receptors, N-Methyl-D-Aspartate/drug effects/*physiology",
          "Synapses/drug effects/*metabolism",
          "Synaptic Transmission/drug effects"
     ],
     "EDAT": "1992/09/01 00:00",
     "MHDA": "1992/09/01 00:01",
     "CRDT": [
          "1992/09/01 00:00"
     ],
     "PHST": [
          "1992/09/01 00:00 [pubmed]",
          "1992/09/01 00:01 [medline]",
          "1992/09/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neuroreport. 1992 Sep;3(9):781-4.",
     "term": "hippocampus"
}